Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Dihesys Digital Health Systems GmbH has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 3 examiners across 3 art units, so the portfolio includes both shared and separate examination assignments.
LIPPERT, JOHN WILLIAM is the busiest examiner, with 2 pending matters. Counsel may find value in coordinating those matters while maintaining separate analysis for the matters assigned elsewhere.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIPPERT, JOHN WILLIAM | 2 | 59.2% | +39.9% |
| GROUX, JENNIFER LILA | 1 | 34.6% | +39.6% |
| KAMM, JUDITH MARIE | 1 | 42.9% | +57.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17783818 | Dot Printing Method And Device For Additive Manufacturing Of Dosage Forms Which Contain Active Substances | GROUX, JENNIFER LILA | 73d overdue |
| 17615431 | Additive Method For 3D Printing Active Ingredient-Containing Objects | KAMM, JUDITH MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17783818 | Dot Printing Method And Device For Additive Manufacturing Of Dosage Forms Which Contain Active Substances | GROUX, JENNIFER LILA | 73d overdue |
| 18258742 | Method For Producing Patient-Optimised Dosage Forms | LIPPERT, JOHN WILLIAM | 60d overdue |
| 17615431 | Additive Method For 3D Printing Active Ingredient-Containing Objects | KAMM, JUDITH MARIE | — |
| 17615450 | Pharmaceutical Dosage Forms and Method For Their Production | LIPPERT, JOHN WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 1754 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18258742 | Method For Producing Patient-Optimised Dosage Forms | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 60d overdue | Pending | Oct 12, 2023 |
| 17783818 | Dot Printing Method And Device For Additive Manufacturing Of Dosage Forms Which Contain Active Substances | GROUX, JENNIFER LILA | 1754 | §103§112 | Final Rejection | 73d overdue | Pending | Dec 14, 2022 |
| 17615431 | Additive Method For 3D Printing Active Ingredient-Containing Objects | KAMM, JUDITH MARIE | 1611 | §103§112 | Non-Final OA | — | Pending | Mar 23, 2022 |
| 17615450 | Pharmaceutical Dosage Forms and Method For Their Production | LIPPERT, JOHN WILLIAM | 1615 | §103 | Non-Final OA | — | Pending | Nov 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDihesys Digital Health Systems GmbH has 4 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
John William Lippert has the most, with 2 of Dihesys Digital Health Systems GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
